View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsPierrel 배당 및 자사주 매입배당 기준 점검 0/6Pierrel 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesNew Risk • Oct 08New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.5% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (91% net debt to equity). Large one-off items impacting financial results. Market cap is less than US$100m (€87.9m market cap, or US$93.1m).New Risk • Sep 25New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€87.3m market cap, or US$93.0m).New Risk • Sep 10New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.8% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€86.0m market cap, or US$92.0m).New Risk • Aug 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 5x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€85.4m market cap, or US$93.9m).공시 • Aug 02Pierrel S.p.A. (BIT:PRL) completed the acquisition of assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million.Pierrel S.p.A. (BIT:PRL) entered into agreements to acquire assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million on May 2, 2023. The purchase consideration payable in cash, is subject to closing and other adjustments. These local anesthetic products had annual sales in 2022 of approximately $30 million. The transaction, which is subject to information or consultation requirements with relevant works councils and other closing conditions, is expected to be completed in the third quarter of 2023. The impact of ongoing operations were not material to 3M's financial results.Pierrel S.p.A. (BIT:PRL) completed the acquisition of assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million. on August 1, 2023.Valuation Update With 7 Day Price Move • Jul 10Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €2.31, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 20x in the Pharmaceuticals industry in Europe. Total loss to shareholders of 42% over the past three years.Valuation Update With 7 Day Price Move • Jun 21Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €2.42, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 21x in the Pharmaceuticals industry in Europe. Total loss to shareholders of 42% over the past three years.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Aug 07Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: €4.83m (up 12% from 2Q 2021). Net loss: €1.00m (loss widened 329% from 2Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 3.1% growth forecast for the industry in Italy.Reported Earnings • Jun 11First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €5.99m (down 8.1% from 1Q 2021). Net income: €542.0k (down 42% from 1Q 2021). Profit margin: 9.1% (down from 14% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 14%, compared to a 5.8% growth forecast for the industry in Italy.Buying Opportunity • Jun 10Now 21% undervaluedOver the last 90 days, the stock is up 8.9%. The fair value is estimated to be €0.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 3.4%. For the next 3 years, revenue is forecast to grow by 17% per annum. Earnings is also forecast to grow by 27% per annum over the same time period.분석 기사 • May 26We Think Pierrel (BIT:PRL) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • May 02Full year 2021 earnings releasedFull year 2021 results: Revenue: €23.8m (up 30% from FY 2020). Net income: €2.94m (up 55% from FY 2020). Profit margin: 12% (up from 10% in FY 2020). The increase in margin was driven by higher revenue.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Nov 18Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €4.96m (up 96% from 3Q 2020). Net income: €673.0k (up €1.31m from 3Q 2020). Profit margin: 14% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue.분석 기사 • Aug 11Does Pierrel (BIT:PRL) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • May 01First quarter 2021 earnings released: EPS €0.004 (vs €0.003 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: €6.52m (up 27% from 1Q 2020). Net income: €940.0k (up 34% from 1Q 2020). Profit margin: 14% (in line with 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.분석 기사 • Apr 05Here's Why Pierrel (BIT:PRL) Has A Meaningful Debt BurdenLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Mar 13Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €18.3m (down 17% from FY 2019). Net income: €1.90m (down 15% from FY 2019). Profit margin: 10% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.분석 기사 • Mar 10Introducing Pierrel (BIT:PRL), A Stock That Climbed 76% In The Last YearIf you want to compound wealth in the stock market, you can do so by buying an index fund. But if you pick the right...Is New 90 Day High Low • Feb 15New 90-day high: €0.24The company is up 42% from its price of €0.17 on 17 November 2020. The Italian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is flat over the same period.분석 기사 • Feb 10Calculating The Fair Value Of Pierrel S.p.A. (BIT:PRL)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Pierrel S.p.A...분석 기사 • Dec 30How Is Pierrel's (BIT:PRL) CEO Paid Relative To Peers?The CEO of Pierrel S.p.A. ( BIT:PRL ) is Fulvio Citaredo, and this article examines the executive's compensation...분석 기사 • Dec 01These 4 Measures Indicate That Pierrel (BIT:PRL) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Nov 16Third quarter 2020 earnings released: €0.003 loss per shareThe company reported a poor third quarter result with weaker earnings, revenues and control over expenses. Third quarter 2020 results: Revenue: €2.54m (down 54% from 3Q 2019). Net loss: €634.0k (down 489% from profit in 3Q 2019). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 19First half earnings releasedOver the last 12 months the company has reported total profits of €3.76m, up 252% from the prior year. Total revenue was €22.7m over the last 12 months, up 7.8% from the prior year.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 PRL 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: PRL 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Pierrel 배당 수익률 vs 시장PRL의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (PRL)n/a시장 하위 25% (IT)1.6%시장 상위 25% (IT)4.5%업계 평균 (Pharmaceuticals)2.7%분석가 예측 (PRL) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 PRL 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 PRL 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 PRL 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: PRL 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIT 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/01/24 03:30종가2024/01/24 00:00수익2023/06/30연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Pierrel S.p.A.는 2명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Luigi TardellaEnVent Capital Markets LimitedFabrizio BariniIntermonte SIM S.p.A.
New Risk • Oct 08New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.5% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (91% net debt to equity). Large one-off items impacting financial results. Market cap is less than US$100m (€87.9m market cap, or US$93.1m).
New Risk • Sep 25New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€87.3m market cap, or US$93.0m).
New Risk • Sep 10New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.8% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€86.0m market cap, or US$92.0m).
New Risk • Aug 07New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Over 5x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risks High level of debt (81% net debt to equity). Profit margins are more than 30% lower than last year (5.6% net profit margin). Market cap is less than US$100m (€85.4m market cap, or US$93.9m).
공시 • Aug 02Pierrel S.p.A. (BIT:PRL) completed the acquisition of assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million.Pierrel S.p.A. (BIT:PRL) entered into agreements to acquire assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million on May 2, 2023. The purchase consideration payable in cash, is subject to closing and other adjustments. These local anesthetic products had annual sales in 2022 of approximately $30 million. The transaction, which is subject to information or consultation requirements with relevant works councils and other closing conditions, is expected to be completed in the third quarter of 2023. The impact of ongoing operations were not material to 3M's financial results.Pierrel S.p.A. (BIT:PRL) completed the acquisition of assets associated with Dental local anesthetic business from 3M Company (NYSE:MMM) for $70 million. on August 1, 2023.
Valuation Update With 7 Day Price Move • Jul 10Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €2.31, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 20x in the Pharmaceuticals industry in Europe. Total loss to shareholders of 42% over the past three years.
Valuation Update With 7 Day Price Move • Jun 21Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to €2.42, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 21x in the Pharmaceuticals industry in Europe. Total loss to shareholders of 42% over the past three years.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Aug 07Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: €4.83m (up 12% from 2Q 2021). Net loss: €1.00m (loss widened 329% from 2Q 2021). Over the next year, revenue is forecast to grow 16%, compared to a 3.1% growth forecast for the industry in Italy.
Reported Earnings • Jun 11First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €5.99m (down 8.1% from 1Q 2021). Net income: €542.0k (down 42% from 1Q 2021). Profit margin: 9.1% (down from 14% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 14%, compared to a 5.8% growth forecast for the industry in Italy.
Buying Opportunity • Jun 10Now 21% undervaluedOver the last 90 days, the stock is up 8.9%. The fair value is estimated to be €0.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 3.4%. For the next 3 years, revenue is forecast to grow by 17% per annum. Earnings is also forecast to grow by 27% per annum over the same time period.
분석 기사 • May 26We Think Pierrel (BIT:PRL) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • May 02Full year 2021 earnings releasedFull year 2021 results: Revenue: €23.8m (up 30% from FY 2020). Net income: €2.94m (up 55% from FY 2020). Profit margin: 12% (up from 10% in FY 2020). The increase in margin was driven by higher revenue.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 18Third quarter 2021 earnings releasedThe company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €4.96m (up 96% from 3Q 2020). Net income: €673.0k (up €1.31m from 3Q 2020). Profit margin: 14% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue.
분석 기사 • Aug 11Does Pierrel (BIT:PRL) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • May 01First quarter 2021 earnings released: EPS €0.004 (vs €0.003 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2021 results: Revenue: €6.52m (up 27% from 1Q 2020). Net income: €940.0k (up 34% from 1Q 2020). Profit margin: 14% (in line with 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
분석 기사 • Apr 05Here's Why Pierrel (BIT:PRL) Has A Meaningful Debt BurdenLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Mar 13Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €18.3m (down 17% from FY 2019). Net income: €1.90m (down 15% from FY 2019). Profit margin: 10% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
분석 기사 • Mar 10Introducing Pierrel (BIT:PRL), A Stock That Climbed 76% In The Last YearIf you want to compound wealth in the stock market, you can do so by buying an index fund. But if you pick the right...
Is New 90 Day High Low • Feb 15New 90-day high: €0.24The company is up 42% from its price of €0.17 on 17 November 2020. The Italian market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is flat over the same period.
분석 기사 • Feb 10Calculating The Fair Value Of Pierrel S.p.A. (BIT:PRL)Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Pierrel S.p.A...
분석 기사 • Dec 30How Is Pierrel's (BIT:PRL) CEO Paid Relative To Peers?The CEO of Pierrel S.p.A. ( BIT:PRL ) is Fulvio Citaredo, and this article examines the executive's compensation...
분석 기사 • Dec 01These 4 Measures Indicate That Pierrel (BIT:PRL) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Nov 16Third quarter 2020 earnings released: €0.003 loss per shareThe company reported a poor third quarter result with weaker earnings, revenues and control over expenses. Third quarter 2020 results: Revenue: €2.54m (down 54% from 3Q 2019). Net loss: €634.0k (down 489% from profit in 3Q 2019). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 19First half earnings releasedOver the last 12 months the company has reported total profits of €3.76m, up 252% from the prior year. Total revenue was €22.7m over the last 12 months, up 7.8% from the prior year.